Victory Capital Management Inc Pds Biotechnology Corp Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$0.65 - $2.6 $1,388 - $5,553	-2,136 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.67 - $3.04 $998 - $4,532	1,491 Added 231.16%	2,136 $2,000
Q4 2019 Feb 04, 2020	SELL	$2.08 - $4.07 $260 - $508	-125 Reduced 16.23%	645 $2,000
Q3 2019 Nov 12, 2019	BUY	$3.38 - $6.71 $2,602 - $5,166	770 New	770 $3,000

4.05M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $46.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.